Impact of Treatment Intensification with Abiraterone on Fracture-related Hospitalisation in Newly Diagnosed Prostate Cancer: A Secondary Analysis of Two Randomised Phase 3 Trials Within the STAMPEDE Trial Platform

Study limitation reported by the research below: “FRH data were derived from Hospital Episode Statistics (HES) in England only, limiting generalisability to other healthcare systems.”